Who Supplies Repaglinide? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Repaglinide exports, with 41+ registered manufacturers shipping to buyers across 36+ countries — yet a handful of companies dominate the shipments. AUROBINDO PHARMA LTD holds the largest share at 23.5% (export value: $1.6M). Close behind, AUROBINDO PHARMA LIMITED (21.2%, $1.5M). USV PRIVATE LIMITED (10.1%, $696.7K). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Repaglinide? Top Manufacturers & Their Buyers
Flow of Repaglinide from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Repaglinide Supplier Network — Key Market Intelligence
The Repaglinide export market from India is led by AUROBINDO PHARMA LTD, which alone commands a 23.5% share, shipping $1.6M worth of product across 265 shipments. The second-largest exporter, AUROBINDO PHARMA LIMITED, contributes $1.5M (21.2%) to the overall market. Combined, the top two suppliers alone account for 44.7% of all Repaglinide exports, indicating a relatively concentrated supply base.
Across all 41 tracked manufacturers, the total Repaglinide export value stands at $6.9M from 819 shipments. The market average shipment value is $8.4K. The single largest buyer relationship in terms of trade value is CSP, receiving $478.6K worth of product.
The combined buyer network spans 17 named purchasing companies, including AUROLOGISTICS LLC(AUROBINDO PHARMA, RISING PHARMA HOLDINGS, INC., AUROLOGISTICS LLC AUROBINDO PHARM, AUROLOGISTICS LLC, ARROW GENERIQUES and 12 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1AUROBINDO PHARMA LTD
AUROBINDO PHARMA LTD is the first-largest Repaglinide exporter from India, with a market share of 23.5% and a total export value of $1.6M across 265 shipments. Their average shipment value of $6.1K is below the market average of $8.4K, reflecting a high-volume, competitive pricing strategy.
AUROBINDO PHARMA LTD serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• AUROLOGISTICS LLC(AUROBINDO PHARMA — $461.1K across 75 shipments (28.4% of this supplier's total exports)
• AUROLOGISTICS LLC(AUROBINDO PHARMA — $440.7K across 72 shipments (27.1% of this supplier's total exports)
• RISING PHARMA HOLDINGS, INC. — $368.6K across 60 shipments (22.7% of this supplier's total exports)
• RISING PHARMA HOLDINGS, INC. — $186.3K across 30 shipments (11.5% of this supplier's total exports)
• AUROLOGISTICS LLC AUROBINDO PHARM — $168.0K across 27 shipments (10.3% of this supplier's total exports)
Key Insight: AUROBINDO PHARMA LTD operates with high shipment frequency (265 shipments) at a per-shipment value of $6.1K, indicating a broad distribution network with many smaller, regular orders.
2AUROBINDO PHARMA LIMITED
AUROBINDO PHARMA LIMITED is the second-largest Repaglinide exporter from India, with a market share of 21.2% and a total export value of $1.5M across 136 shipments. Their average shipment value of $10.8K is above the market average of $8.4K, suggesting premium or bulk contract pricing.
AUROBINDO PHARMA LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• RISING PHARMA HOLDINGS, INC. — $463.1K across 43 shipments (31.6% of this supplier's total exports)
• AUROLOGISTICS LLC AUROBINDO PHARM — $443.2K across 41 shipments (30.3% of this supplier's total exports)
• AUROLOGISTICS LLC — $322.2K across 30 shipments (22.0% of this supplier's total exports)
• ARROW GENERIQUES — $124.5K across 12 shipments (8.5% of this supplier's total exports)
• AURO PHARMA INC, — $111.2K across 10 shipments (7.6% of this supplier's total exports)
Key Insight: AUROBINDO PHARMA LIMITED's per-shipment value of $10.8K is 28% above the market average of $8.4K, consistent with large-order contracts or value-added formulations.
3USV PRIVATE LIMITED
USV PRIVATE LIMITED is the third-largest Repaglinide exporter from India, with a market share of 10.1% and a total export value of $696.7K across 46 shipments. Their average shipment value of $15.1K is above the market average of $8.4K, suggesting premium or bulk contract pricing.
USV PRIVATE LIMITED serves 5 named buyers in our database. CSP is the dominant customer, accounting for 68.7% of this supplier's tracked business. Top customers include:
• CSP — $478.6K across 32 shipments (68.7% of this supplier's total exports)
• DELTA IMPORT EXPORT MEDICAL CO. LTD — $84.6K across 6 shipments (12.1% of this supplier's total exports)
• DELTA IMPORT-EXPORT — $83.4K across 6 shipments (12.0% of this supplier's total exports)
• MERCKLE GMBH — $26.0K across 2 shipments (3.7% of this supplier's total exports)
• PHARMAS D.O.O — $24.0K across 2 shipments (3.5% of this supplier's total exports)
Key Insight: USV PRIVATE LIMITED's per-shipment value of $15.1K is 79% above the market average of $8.4K, consistent with large-order contracts or value-added formulations.
4MACLEODS PHARMACEUTICALS LTD
MACLEODS PHARMACEUTICALS LTD is the fourth-largest Repaglinide exporter from India, with a market share of 3.9% and a total export value of $267.7K across 17 shipments. Their average shipment value of $15.7K is above the market average of $8.4K, suggesting premium or bulk contract pricing.
MACLEODS PHARMACEUTICALS LTD serves 4 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• MACLEODS PHARMA USA INC — $118.1K across 7 shipments (44.1% of this supplier's total exports)
• MACLEODS PHARMA USA INC — $77.9K across 5 shipments (29.1% of this supplier's total exports)
• MACLEODS PHARMA USA INC — $37.4K across 2 shipments (14.0% of this supplier's total exports)
• MACLEODS PHARMA USA INC — $34.3K across 2 shipments (12.8% of this supplier's total exports)
Key Insight: MACLEODS PHARMACEUTICALS LTD's per-shipment value of $15.7K is 86% above the market average of $8.4K, consistent with large-order contracts or value-added formulations.
5INTAS PHARMACEUTICALS LIMITED
INTAS PHARMACEUTICALS LIMITED is the fifth-largest Repaglinide exporter from India, with a market share of 3.4% and a total export value of $233.2K across 173 shipments. Their average shipment value of $1.3K is below the market average of $8.4K, reflecting a high-volume, competitive pricing strategy.
INTAS PHARMACEUTICALS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• NOVATIN LIMITED — $96.1K across 71 shipments (41.2% of this supplier's total exports)
• NOVATIN LIMITED CONS — $53.1K across 39 shipments (22.8% of this supplier's total exports)
• TO THE ORDER., — $37.0K across 27 shipments (15.9% of this supplier's total exports)
• NOVATIN LTD CONSIGNE — $23.6K across 18 shipments (10.1% of this supplier's total exports)
• BROCACEF NL : HUB — $23.4K across 17 shipments (10.0% of this supplier's total exports)
Key Insight: INTAS PHARMACEUTICALS LIMITED operates with high shipment frequency (173 shipments) at a per-shipment value of $1.3K, indicating a broad distribution network with many smaller, regular orders.
6GLOBAL PHARMA HEALTHCARE PRIVATE LIMITED
GLOBAL PHARMA HEALTHCARE PRIVATE LIMITED is the fifth-largest Repaglinide exporter from India, with a market share of 0.5% and a total export value of $33.1K across 15 shipments. Their average shipment value of $2.2K is below the market average of $8.4K, reflecting a high-volume, competitive pricing strategy.
GLOBAL PHARMA HEALTHCARE PRIVATE LIMITED serves 1 named buyer in our database. TELPHA INC is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• TELPHA INC — $33.1K across 15 shipments (100.0% of this supplier's total exports)
Key Insight: GLOBAL PHARMA HEALTHCARE PRIVATE LIMITED operates with high shipment frequency (15 shipments) at a per-shipment value of $2.2K, indicating a broad distribution network with many smaller, regular orders.
From Indian Factories to Global Pharmacies — How Repaglinide Flows
Once Repaglinide leaves the manufacturing plants of companies like AUROBINDO PHARMA LTD and AUROBINDO PHARMA LIMITED, it travels to 5 destination markets with a combined import value of $6.9M. United States absorbs the largest share at 60.4% ($4.2M), followed by France (15.7%) and Canada (7.3%).
In United States — the top destination — named importers include AUROLOGISTICS LLC (AUROBINDO PHARMA, AUROLOGISTICS LLC, (AUROBINDO PHARM, RISING PHARMA HOLDINGS INC. In France, key buyers are ARROW GENERIQUES,, ARROW GENERIQUES.
This geographic spread reflects Repaglinide's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Repaglinide Go? Top Importing Countries & Their Buyers
Trade flow of Repaglinide exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1United States
United States ranks as the first-largest destination for Repaglinide imports from India, with a total trade value of $4.2M across 116 shipments — representing a 60.4% share of all Repaglinide exports. The average shipment value of $36.0K is above the global average of $8.4K, indicating high-value procurement contracts or branded formulations. This market is served by 11 tracked buyers.
Named Repaglinide importers in United States: AUROLOGISTICS LLC (AUROBINDO PHARMA is the largest buyer, accounting for 12.2% ($511.2K) of this market's total imports.
• AUROLOGISTICS LLC (AUROBINDO PHARMA — $511.2K (12.2% of United States's total)
• AUROLOGISTICS LLC, (AUROBINDO PHARM — $483.3K (11.6% of United States's total)
• RISING PHARMA HOLDINGS INC — $463.1K (11.1% of United States's total)
Key Insight: United States's per-shipment average of $36.0K (326% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United States is a key market for Repaglinide imports from India.
2France
France ranks as the second-largest destination for Repaglinide imports from India, with a total trade value of $1.1M across 94 shipments — representing a 15.7% share of all Repaglinide exports. The average shipment value of $11.6K is above the global average of $8.4K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Repaglinide importers in France: ARROW GENERIQUES, is the largest buyer, accounting for 31.4% ($341.2K) of this market's total imports.
• ARROW GENERIQUES, — $341.2K (31.4% of France's total)
• ARROW GENERIQUES — $156.2K (14.4% of France's total)
Key Insight: France's per-shipment average of $11.6K (37% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
France is a key market for Repaglinide imports from India.
3Canada
Canada ranks as the third-largest destination for Repaglinide imports from India, with a total trade value of $503.4K across 29 shipments — representing a 7.3% share of all Repaglinide exports. The average shipment value of $17.4K is above the global average of $8.4K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.
Named Repaglinide importers in Canada: AURO PHARMA INC, is the largest buyer, accounting for 50.9% ($256.4K) of this market's total imports.
• AURO PHARMA INC, — $256.4K (50.9% of Canada's total)
• AURO PHARMA INC., — $124.2K (24.7% of Canada's total)
• AURO PHARMA INC — $122.8K (24.4% of Canada's total)
Key Insight: Canada's per-shipment average of $17.4K (106% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Canada is a key market for Repaglinide imports from India.
4Vietnam
Vietnam ranks as the fourth-largest destination for Repaglinide imports from India, with a total trade value of $272.7K across 2 shipments — representing a 3.9% share of all Repaglinide exports. The average shipment value of $136.4K is above the global average of $8.4K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Repaglinide importers in Vietnam: DELTA IMPORT EXPORT MEDICAL CO. LTD is the largest buyer, accounting for 31.0% ($84.6K) of this market's total imports.
• DELTA IMPORT EXPORT MEDICAL CO. LTD — $84.6K (31.0% of Vietnam's total)
Key Insight: Vietnam's per-shipment average of $136.4K (1515% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Vietnam is a key market for Repaglinide imports from India.
5Croatia
Croatia ranks as the fifth-largest destination for Repaglinide imports from India, with a total trade value of $246.6K across 6 shipments — representing a 3.6% share of all Repaglinide exports. The average shipment value of $41.1K is above the global average of $8.4K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Repaglinide importers in Croatia: NOVATIN LIMITED is the largest buyer, accounting for 38.9% ($96.1K) of this market's total imports.
• NOVATIN LIMITED — $96.1K (38.9% of Croatia's total)
Key Insight: Croatia's per-shipment average of $41.1K (387% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Croatia is a key market for Repaglinide imports from India.
People Also Ask — Repaglinide Supplier & Trade Network
Who are the top suppliers of Repaglinide from India?+
Which companies buy Repaglinide from Indian manufacturers?+
Where does Repaglinide exported from India go?+
What is the market share of the top Repaglinide supplier from India?+
What is the average shipment value for Repaglinide exports from India?+
Is Repaglinide manufactured in India and exported globally?+
Which country imports the most Repaglinide from India?+
Who are the buyers of Repaglinide in France?+
How concentrated is the Repaglinide supplier market in India?+
How do I find verified buyers for Repaglinide in specific countries?+
Repaglinide Trade Network — Key Takeaways
- 1AUROBINDO PHARMA LTD is India's dominant Repaglinide exporter with a 23.5% market share and $1.6M in total exports — making it the single most important sourcing entity in this market.
- 2The top 41 suppliers collectively account for 62.5% of all tracked Repaglinide exports, with a combined trade value of $6.9M.
- 3United States is the largest destination market, absorbing 60.4% of India's Repaglinide exports ($4.2M). France (15.7%) and Canada (7.3%) follow.
- 4With 819 total shipments averaging $8.4K each, the Repaglinide export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include AUROLOGISTICS LLC(AUROBINDO PHARMA, AUROLOGISTICS LLC(AUROBINDO PHARMA, RISING PHARMA HOLDINGS, INC., AUROLOGISTICS LLC AUROBINDO PHARM — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 5 customers
6 suppliers → 36 countries
Network value: $6.9M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Repaglinide — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Repaglinide.
- 2.Flow Mapping: 41 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 819 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 36 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
819 Verified Shipments
41 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists